SCHEMBL1940773

SCHEMBL1940773

COc1ccc(C(=O)c2cn(C(C)C)c3ncnc(N)c23)cc1NC(=O)NC(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 5/20 0.55
NTRK2 Q16620 3/20 0.55
NTRK3 Q16288 2/20 0.55
PDGFRB P09619 1/20 0.55
TEK Q02763 4/20 0.52
EGFR P00533 3/20 0.52
ERBB2 P04626 2/20 0.52
ERBB3 P21860 2/20 0.52
ERBB4 Q15303 2/20 0.52
RET P07949 6/20 0.49
KCNH2 Q12809 3/20 0.48
PDPK1 O15530 3/20 0.48
LCK P06239 4/20 0.46
SRC P12931 2/20 0.46
KDR P35968 5/20 0.42
PIK3CD O00329 1/20 0.41
ABL1 P00519 1/20 0.41
PIK3CA P42336 1/20 0.41
PIK3CG P48736 1/20 0.41
BACE1 P56817 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1941196 0.91 NTRK1 (0.59) NTRK1NTRK2NTRK3PDGFRBTEK
SCHEMBL1941531 0.89 PDGFRB (0.66) NTRK1NTRK2NTRK3PDGFRBTEK
SCHEMBL1940050 0.89 PDGFRB (0.57) NTRK1NTRK2NTRK3PDGFRBTEK
SCHEMBL1939979 0.88 PDGFRB (0.62) NTRK1NTRK2NTRK3PDGFRBTEK
SCHEMBL1941041 0.88 PDGFRB (0.60) NTRK1NTRK2NTRK3PDGFRBTEK
SCHEMBL1940223 0.88 PDGFRB (0.62) NTRK1NTRK2NTRK3PDGFRBTEK
SCHEMBL1942150 0.88 NTRK1 (0.53) NTRK1NTRK2NTRK3PDGFRBTEK
SCHEMBL1941620 0.88 PDGFRB (0.62) NTRK1NTRK2NTRK3PDGFRBTEK
SCHEMBL1939776 0.88 NTRK1 (0.63) NTRK1NTRK2NTRK3PDGFRBTEK
SCHEMBL1940250 0.88 EGFR (0.55) NTRK1NTRK2NTRK3PDGFRBTEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578751-B1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PROD INC (US) 2011-06-15 EP disclosed
US-7271262-B2 Pyrrolopyrimidine derivatives PFIZER INC (US) 2007-09-18 US disclosed
EP-1578751-A1 PYRROLOPYRIMIDINE DERIVATIVES Pfizer Products Inc. (US) 2005-09-28 EP disclosed
US-20050037999-A1 Pyrrolopyrimidine derivatives PFIZER INC 2005-02-17 US disclosed
WO-2004056830-A1 PYRROLOPYRIMIDINE DERIVATIVES PFIZER PRODUCTS INC. (US) 2004-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050037999-A1 Pyrrolopyrimidine derivatives CCNA1, CCNT1, TP53 NTRK1 4135/4885NTRK2 4651/4885NTRK3 4212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.